month, I mentioned our current efforts to gather thoughts about
LongeCity's objectives in 2016. Earlier this month I had the opportunity
to catch up in person with some LongeCity founding members, including
our current co-manager and broadcaster Justin ‘Mind’
Schloendorn who now runs his
own lab, Justin ‘E-Traveller’
Rebo, who recently completed a productive research visit at Stanford,
Perrott who continues to set important policy impulses while based at
the Buck Institute. I was
also lucky to catch up with some valued affiliates, like Kristen
who has turned her computational biology expertise into a venture,
Stolzing, who now runs labs in the UK and Germany; and Matthew ‘Oki’
O'Connor and the great people at SENS
Foundation who are busy planning a publication and a conference
(more on that in an upcoming newsletter). And there are a so many
others who I could have met or mentioned here who, in there different
ways pursue the LongeCity mission full-time across the
I was also thrilled to meet some fresh faces who were interested in
getting involved LongeCity. And others who, while having
registered an account ages ago, don't really visit much. Many of us will have had
a similar experience:
The interest in the mission persists, but the appetite for forum
conversations waxes and wanes.
What does this mean for LongeCity policy, especially in the context of
our upcoming strategy discussion?
● Firstly, I think our continued efforts to encourage local
meetings are worth persisting with. While LongeCity will always be,
first and foremost, a cyber-space, the 'special something' that
in-person meetings bring can be very valuable and productive.
● There are LongeCity friends out there to tackle our mission from
different scientific angles and act as mentors. To strengthen these
links, there is a plan to radically change our science support budget,
by focusing on the ‘affiliate
● Moreover, and perhaps most importantly, there really is
great value in cultivating an international network of professionals and
promoters. To this end, we could all strengthen our individual and
collective effort to develop the LongeCity “CONNECT”
Do you have other ideas about LongeCity’s strategy for 2016? There are
just a few days remaining for Members to
register their interest.
In this months podcast, Mind interviews Dr
David Spiegel who recently achieved a breakthrough synthesis
of Glucosepane, regarded as one of the key indigestible extracellular cross-link molecules that accumulates as humans age and causes stiffening and malfunction of many tissues.
Dr Spiegel talks about how having the molecule readily available for research could advance anti-aging treatments.
--> Podcast and discussion.